You have 9 free searches left this month | for more free features.

Semaglutide

Showing 1 - 25 of 362

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Scleroderma, Systemic, Fibrosis, Semaglutide Trial (Semaglutide Pen Injector)

Not yet recruiting
  • Scleroderma, Systemic
  • +2 more
  • Semaglutide Pen Injector
  • (no location specified)
Nov 20, 2023

Healthy Participants Trial in Cypress (Semaglutide J, Semaglutide C)

Recruiting
  • Healthy Participants
  • Semaglutide J
  • Semaglutide C
  • Cypress, California
    Novo Nordisk Investigational Site
Mar 28, 2023

Obesity Trial in Berlin (Semaglutide D Dose 1, Semaglutide D Dose 2, Semaglutide D Dose 3)

Completed
  • Obesity
  • Semaglutide D Dose 1
  • +6 more
  • Berlin, Germany
    Novo Nordisk Investigational Site
Dec 12, 2022

Healthy Volunteers (Diabetes, Type 2) Trial in Harrow (Semaglutide B, 1.34 mg/mL, Semaglutide D, 1.0 mg/mL)

Completed
  • Healthy Volunteers (Diabetes Mellitus, Type 2)
  • Semaglutide B, 1.34 mg/mL
  • Semaglutide D, 1.0 mg/mL
  • Harrow, Middlesex, United Kingdom
    Novo Nordisk Investigational Site
Jan 29, 2023

Semaglutide Use in Acute Pulmonary Embolism

Completed
  • Pulmonary Embolism
  • Semaglutide
  • London, United Kingdom
    Colm McCabe
Nov 3, 2023

Type 2 Diabetes Trial in Jinan (Semaglutide, Semaglutide Pen Injector [Ozempic])

Not yet recruiting
  • Type 2 Diabetes
  • Semaglutide
  • Semaglutide Pen Injector [Ozempic]
  • Jinan, Shandong, China
    Shandong Provincial Hospital
Jul 11, 2023

Alcohol Use Disorder Trial in Aurora (Semaglutide 3 MG [Rybelsus], Semaglutide 7 MG [Rybelsus], Placebo)

Not yet recruiting
  • Alcohol Use Disorder
  • Semaglutide 3 MG [Rybelsus]
  • +2 more
  • Aurora, Colorado
    University of Colorado Anschutz Medical Campus
Jun 6, 2023

Alcohol Use Disorder Trial in Tulsa (Semaglutide, Placebo)

Not yet recruiting
  • Alcohol Use Disorder
  • Semaglutide
  • Placebo
  • Tulsa, Oklahoma
    OSU Biomedical Imaging Center
Jun 5, 2023

Healthy Participants Trial in Neuss (Semaglutide)

Not yet recruiting
  • Healthy Participants
  • Semaglutide
  • Neuss, Germany
    Novo Nordisk Investigational Site
Aug 10, 2023

Liver Transplant; Complications, Diabete Mellitus Trial (Semaglutide Pill)

Not yet recruiting
  • Liver Transplant; Complications
  • Diabete Mellitus
  • Semaglutide Pill
  • (no location specified)
Sep 23, 2023

Addiction, Alcohol Use Disorder Trial in Baltimore (Take Control, Semaglutide)

Recruiting
  • Addiction
  • Alcohol Use Disorder
  • Take Control
  • Semaglutide
  • Baltimore, Maryland
    National Institute on Drug Abuse
Sep 2, 2023

Genetic Predisposition, Metabolic Diseases, Type 2 Diabetes Trial (Mixed Meal Tolerance Test (MMTT), Rybelsus)

Not yet recruiting
  • Genetic Predisposition
  • +2 more
  • (no location specified)
Aug 18, 2023

Non-alcoholic Steatohepatitis Trial in Montreal (NNC0194-0499, Semaglutide, NNC0194-0499/Semaglutide A (40/3.20 mg/mL))

Not yet recruiting
  • Non-alcoholic Steatohepatitis
  • Montreal, Quebec, Canada
    Novo Nordisk Investigational Site
Mar 9, 2023

Diabetic Kidney Disease, Type 1 Diabetes Trial (Semaglutide, Placebo)

Not yet recruiting
  • Diabetic Kidney Disease
  • Type 1 Diabetes
  • Semaglutide
  • Placebo
  • (no location specified)
Apr 18, 2023

Healthy Volunteers, Type 2 Diabetes Trial in Overland Park (Semaglutide D Dose 1, Semaglutide D Dose 2, Semaglutide D Dose 3)

Active, not recruiting
  • Healthy Volunteers
  • Type 2 Diabetes
  • Semaglutide D Dose 1
  • +5 more
  • Cypress, California
  • +2 more
Dec 27, 2022

Gastric Content of Volunteers Fasting and Using

Completed
  • Pneumonia, Aspiration
  • Anesthesia
  • semaglutide use
  • Sao Paulo, Brazil
    Hospital Israelita Albert Einstein
Dec 1, 2023

Diabetes, Type 2 Trial in San Antonio (Oral semaglutide)

Recruiting
  • Diabetes Mellitus, Type 2
  • Oral semaglutide
  • San Antonio, Texas
    Novo Nordisk Investigational Site
Nov 18, 2022

Type 2 Diabetes, Osteopenia Trial in Odense (oral Semaglutide/Rybelsus, Placebo)

Not yet recruiting
  • Type 2 Diabetes
  • Osteopenia
  • oral Semaglutide/Rybelsus
  • Placebo
  • Odense, Denmark
    Odense University Hospital
Sep 21, 2023

Diabetes, Type 1 Trial in Aurora (Semaglutide Pen Injector, Placebo)

Recruiting
  • Diabetes Mellitus, Type 1
  • Semaglutide Pen Injector
  • Placebo
  • Aurora, Colorado
    University of Colorado Anschutz Medical Campus
Apr 20, 2023

Type 1 Diabetes Trial (Semaglutide weekly injection)

Not yet recruiting
  • Type 1 Diabetes
  • Semaglutide weekly injection
  • (no location specified)
Sep 21, 2023

PCOS (Polycystic Ovary Syndrome), Semaglutide Trial in Peking (Metformin Hydrochloride 500 MG, Semaglutide, 1.34 mg/mL,

Not yet recruiting
  • PCOS (Polycystic Ovary Syndrome)
  • Semaglutide
  • Metformin Hydrochloride 500 MG
  • +4 more
  • Peking, Beijing, China
    PekingUFH
Jan 18, 2023

Obesity, Interstitial Lung Disease, COPD Trial (Semaglutide Pen Injector)

Not yet recruiting
  • Obesity
  • +4 more
  • Semaglutide Pen Injector
  • (no location specified)
Feb 15, 2023

Cystic Fibrosis, Cystic Fibrosis-related Diabetes Trial in Minneapolis (Semaglutide)

Not yet recruiting
  • Cystic Fibrosis
  • Cystic Fibrosis-related Diabetes
  • Semaglutide
  • Minneapolis, Minnesota
    University of Minnesota
Mar 15, 2023

PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Obese Trial (Semaglutide)

Not yet recruiting
  • PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
  • Obese
  • Semaglutide
  • (no location specified)
Apr 6, 2023

Hyperglycemia, Renal Transplant Complication Primary Non-Function, Diabetes Trial (Semaglutide 14 MG [Rybelsus], Placebo)

Not yet recruiting
  • Hyperglycemia
  • +2 more
  • Semaglutide 14 MG [Rybelsus]
  • Placebo
  • (no location specified)
Feb 1, 2023